Prenatal Human Milk Oligosaccharides (HMOs) in the Context of BMI, Gestational Weight Gain, and Lipid Profile—An Association Study in Pregnant Women with Overweight or Obesity

Abstract

BackgroundHuman milk oligosaccharides (HMOs) are bioactive glycans first detected in human milk. Their presence in maternal blood during pregnancy suggests systemic functions. Dynamics and associations of the most abundant prenatal HMOs in relation to maternal BMI and serum lipids in a cohort of 87 pregnant women with either overweight or obesity are studied.MethodsSerum HMOs (2’FL, 3’SL, 3’SLN, LDFT), serum lipids (total cholesterol, HDL, LDL, triglycerides), and BMI are measured at 15, 24, and 32 weeks of gestation.Results2’FL and LDFT are negatively correlated to pre‐pregnancy BMI and increase significantly slower between 15 and 24 weeks in highly obese women. Women without detectable increase of serum 2’FL (non‐secretors) show a less pronounced gestational weight gain and lower BMI in the third trimester as compared to women phenotype as secretors. Higher early‐pregnancy 2’FL is associated with high HDL and low triglycerides in pregnancy. On the other hand, higher 3’SL at 15 weeks is associated with higher triglycerides, LDL, and total cholesterol.ConclusionsHigher early‐pregnancy 2’FL is associated with a cardioprotective lipid profile, whereas higher 3’SL is associated with an atherogenic lipid profile. Serum trajectories of 2’FL and LDFT in obese women suggest an obesity mediated delay of α‐1,2‐fucosylation.